跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
威络益 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Zolbetuximab for Injection
Approved
生物制品
Zolbetuximab for Injection
ASTELLAS PHARMA EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Dec 25, 2024
Approval ID
8fv533lQu44
Company
ASTELLAS PHARMA EUROPE B.V.
Type
生物制品
Approval Details
Approval Id
8fv533lQu44
Approval Number
国药准字SJ20240050
Generic Name
注射用佐妥昔单抗
Generic Name En
Zolbetuximab for Injection
Trade Name
威络益
Drug Type
生物制品
Dosage Form
注射剂
Strength
100mg/瓶
Reg Date
2024-12-25
Expired Date
2029-12-24
Company Name
ASTELLAS PHARMA EUROPE B.V.
Production Company Name
Baxter Oncology GmbH
Company Detail Path
/organization/astellas-pharma-europe-b-v
Production Company Detail Path
/organization/baxter-oncology-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 25, 2024
Approval ID
8fv533lQu44
Type
生物制品
Back to NMPA Approvals